Successful proof of concept at GSK employs data transfer via cloud to facilitate secure and efficient collaboration across companies, labs and time zones.

Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.

Kuano, announced the close of its £1.8M seed funding round. The investment will facilitate further validation of Kuano’s quantum simulation platform for the design of more effective drug candidates targeting enzymes.

Novartis presents new patient-reported outcomes (PRO) data from the Phase III NATALEE trial at the European Society for Medical Oncology (ESMO) Virtual Plenary.

A new partnership to provide customers with direct access to highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays. These will alleviate the need for stringent in-house quality control testing to maximize assay success.

Optibrium, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology.

ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies.

RemeGen Co., Ltd. announced that their Phase II clinical study of telitacicept for the treatment of Primary Sjögren's Syndromein adults has been published.

Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment.

Metrion Biosciences announced it has received notification from the MHRA that the Company is now a member of the UK GLP Compliance Monitoring Programme.